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Human ES cell derivationMouse embryos segregate three different lineages during preimplantation development: trophoblast, epi-
blast and hypoblast. These differentiation processes are associated with restricted expression of key tran-
scription factors (Cdx2, Oct4, Nanog and Gata6). The mechanisms of segregation have been extensively
studied in the mouse, but are not as well characterised in other species. In the human embryo, hypoblast dif-
ferentiation has not previously been characterised. Here we demonstrate co-exclusive immunolocalisation of
Nanog and Gata4 in human blastocysts, implying segregation of epiblast and hypoblast, as in rodent embryos.
However, the formation of hypoblast in the human is apparently not dependent upon FGF signalling, in con-
trast to rodent embryos. Nonetheless, the persistence of Nanog-positive cells in embryos following treatment
with FGF inhibitors is suggestive of a transient naïve pluripotent population in the human blastocyst, which
may be similar to rodent epiblast and ES cells but is not sustained during conventional human ES cell deriva-
tion protocols.
© 2011 Elsevier Inc.Open access under CC BY license. Introduction
The mouse embryo undergoes two crucial lineage segregation
events before implantation in the uterus. The ﬁrst is the separation
of trophectoderm from the inner cell mass (ICM); the second is the
segregation of the epiblast and hypoblast in the ICM. The trophecto-
derm and hypoblast lineages give rise to extra-embryonic tissues
that facilitate the implantation of the embryo into the uterus and for-
mation of the placenta. The epiblast forms a pool of pluripotent cells
that will give rise to the foetus in collaboration with patterning sig-
nals from the extra-embryonic tissues (Beddington and Robertson,
1999; Gardner and Beddington, 1988). The pre-implantation epiblast
is also the source of embryonic stem (ES) cells (Brook and Gardner,
1997).
The separation of the trophectoderm and ICM in mouse embryos
is marked by mutually exclusive expression of the two transcription
factors Oct4 and Cdx2 (Niwa et al., 2005). The segregation of epiblast
and hypoblast from the cells of the ICM is suggested to involve Nanog
and Gata6. These two factors are initially expressed in an overlapping
manner in the ICM but then become mutually exclusive in the late
mouse blastocyst (Chazaud et al., 2006; Plusa et al., 2008). EpiblastStem Cell Research, University
UK. Fax: +44 1223 760241.
icense. and hypoblast lineages are morphologically distinct within the mu-
rine ICM by embryonic day (E) 4.5, just before implantation.
Studying the mechanisms of early lineage segregation has provided
insight into how the pluripotent epiblast is speciﬁed, and this has en-
abled development of efﬁcient strategies to isolate ES cells frommurine
embryos, either by physical separation (Brook and Gardner, 1997) or
application of speciﬁc inhibitors to block differentiation (Buehr et al.,
2008; Li et al., 2008; Nichols et al., 2009; Ying et al., 2008).
Pluripotency is deﬁned as the ability of a cell to give rise to differ-
ent tissues representative of all three of the embryonic germ layers:
ectoderm, mesoderm and endoderm. It can be considered as two
states (Nichols and Smith, 2009). Naïve (or ‘ground state’) pluripo-
tency is represented by the newly segregated pre-implantation epi-
blast and rodent ES cells. Following implantation, the epiblast
responds to signals from the extra-embryonic tissues and becomes
primed for differentiation. Primed pluripotency is also exhibited by
the epiblast stem cell lines (EpiSCs) derived from post-implantation
epiblasts in culture (Brons et al., 2007; Tesar et al., 2007). In addition
to their ability to give rise to multiple tissue types, naïve and primed
pluripotent cells are both characterised by expression of the core
pluripotency factors Oct4, Sox2 and Nanog, but differ in their expres-
sion spectrum of other genes, their culture requirements and their
ability to resume normal development when placed in the embryonic
environment. Interestingly, although pluripotent cell lines have been
derived from primate blastocysts (Suemori et al., 2001; Thomson
et al., 1995; Thomson et al., 1998), these cells more closely resemble
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niﬁcantly, both primate ES cells and EpiSCs require exogenous FGF in
order to self-renew, in contrast to rodent ES cells.
Naïve pluripotency can readily be captured from embryos of mice
and rats when ﬁbroblast growth factor (FGF)/Erk signalling are inhib-
ited in combination with glycogen synthase kinase 3 (GSK3) inhibi-
tion, a system known as ‘2i’, short for ‘two inhibitors’ (Buehr et al.,
2008; Li et al., 2008; Nichols et al., 2009; Ying et al., 2008). Analysis
of murine embryos cultured from the 8-cell-stage in 2i revealed that
the resulting ICM consisted almost entirely of cells expressing high
levels of Nanog and no Gata4, indicating that putative hypoblast
cells had become epiblast (Nichols et al., 2009). The efﬁcient deriva-
tion of murine ES cells in 2i may therefore be attributable in part to
blockade of hypoblast. Further evidence that formation of hypoblast
in the mouse is dependent upon FGF signalling is provided by the
demonstration that supplementation of the embryo culture medium
with high levels of recombinant FGF4 diverts ICM cells to hypoblast
(Yamanaka et al., 2010).
The 2i culture regime provides a highly selective environment in
which cells not exhibiting properties of naive pluripotency fail to thrive,
and are thus eliminated. EpiSCs and human ES cells do not survive in 2i
(Guo et al., 2009; Nichols and Smith, 2009). So far there have been no
reports of the derivation of naïve pluripotent cells fromnon-rodent em-
bryos. For practical purposes, naïve human ES cells would be highly de-
sirable, but attempts to generate human ES cells by culturing embryos
in 2i have failed (JN, MR, unpublished). We have attempted to ﬁnd an
explanation for this failure by ﬁrst investigating lineage segregation in
human embryos, then analysing their responses to the application of in-
hibitors, speciﬁcally in the maintenance of Nanog expression and the
emergence of Gata4-expressing cells.
Materials and methods
Human embryos
Human embryos surplus to IVF requirements were donated to re-
search after informed patient consent, with approval of local ethics
committees and the UK Human Fertilisation and Embryology Author-
ity (Research licence R0178). Embryos were obtained from Bourn Hall
Clinic, Cambridgeshire. Embryos were thawed using EmbroThawTM
Kit (EMF40_T, Fertipro) according to the manufacturer's instructions.
Embryos were cultured to day 3 in EmbryoAssist™ (12140010, Ori-
gio), after which they were changed to BlastAssist® (12160010, Ori-
gio) until the appearance of a cavity, upon which they were
transferred to N2B27 medium (SCS-SF-NB-02, Stem Cell Sciences)
(Nichols and Ying, 2006; Ying and Smith, 2003) for further culture.
Embryos were cultured in 50 μl drops of medium under mineral oil
(MINOIL500, Fertipro) and changed to fresh medium every 2 days.
Embryos were cultured in a humidiﬁed atmosphere at 5% oxygen,
7% carbon dioxide and 37 °C. Embryos were exposed to inhibitors
from day 3 of development.
Culture mediumwas supplemented with inhibitors in the combina-
tions speciﬁed in the text: PD0325901, a Mek inhibitor with an IC50
value in the 20–50 nM range in human cells (Ciuffreda et al., 2009),
0.5 μM or 1 μM; Chir99021, a GSK3β inhibitor with an IC50 value of
10 nM in human cells (Ring et al., 2003), 3 μM (both synthesised in the
Division of Signal Transduction Therapy, University of Dundee, Dundee,
UK) and PD173074 (Sigma), a pan-FGF receptor inhibitor with an IC50
value in the range of 5–22 nM for human FGFR1–5 (Byron et al., 2008;
Grand et al., 2004; Mohammadi et al., 1998; Skaper et al., 2000;
St Bernard et al., 2005; Stavridis et al., 2007), 100 nM.
Rodent embryos
The strains of mice used in this study were MF1 outbred, and F1
hybrids between C57BL/6/Ola and CBA/Ca. The strain of rat usedwas Sprague–Dawley (SD). Animals were maintained by in-house
breeding on a lighting regime of 14 hours light and 10 hours darkness
with food and water supplied ad libitum. Prior to caging with stud
males, female mice were oestrous selected by visual inspection of
the vagina (Champlin et al., 1973). Female rats were selected for oes-
trus using a vaginal impedance monitor (Muromachi Kikai, Tokyo,
Japan, MK-11)(Koto et al., 1987). Detection of a copulation plug the
following morning was used to conﬁrm successful mating; the result-
ing embryos were then considered to be E0.5. For all experiments, the
embryos from at least two females were pooled and randomly
assigned to experimental groups. Mouse and rat embryos were
ﬂushed from oviducts using M2 medium at E2.5 and E3.5 respective-
ly. Mouse embryos were cultured in BlastAssist® for 2 days before
being moved to N2B27 as expanded blastocysts. Rat embryos were
cultured in BlastAssist® for 1 day, after which they were switched
to N2B27. Embryos were cultured at 5% oxygen, 7% carbon dioxide
and 37 °C.
Immunostaining
Embryos were processed for immunohistochemistry as described
previously (Nichols et al., 2009). Brieﬂy, they were ﬁxed in 4% para-
formaldehyde in PBS for 15 minutes, then rinsed in PBS containing
3 mg/ml polyvinylpyrolidone (PBS/PVP; P0930, Sigma), permeabi-
lised in PBS/PVP containing 0.25% Triton X-100 (23,472-9, Sigma)
for 30 minutes and blocked in blocking buffer, which comprised PBS
containing 0.1% BSA, 0.01% Tween 20 (P1379, Sigma) and 2% donkey
serum. Primary antibodies were Oct4 (C-10 sc-5279, Santa Cruz Bio-
tech, Santa Cruz, CA, USA), Nanog (ab21624 or ab21603, Abcam, Cam-
bridge, UK), Gata4 (C-20 sc-1237, Santa Cruz), Gata6 (R&D Systems,
AF1700) and Sox17 (R&D Systems, AF1924). Antibodies were diluted
1:100 (Oct-4 was used at 1:200) in blocking buffer and embryos were
incubated in the appropriate antibody solution at 4 °C overnight. They
were rinsed three times in blocking buffer for 15 minutes each, and
incubated in secondary antibody solution for 1 hour at room temper-
ature. Secondary antibodies raised in Donkey labelled with Alexa
ﬂuorophores (Invitrogen, Paisley, UK) were diluted 1:500 in blocking
buffer (anti-mouse IgG2b for Oct4:647; anti-rabbit IgG for Nanog:488;
anti-goat IgG for Gata4, Gata6 and Sox17:555). Embryos were then
rinsed three times in blocking buffer, incubated brieﬂy in increasing
concentrations of Vectashield (H-1200, Vector Labs, Peterborough,
UK) before mounting on glass slides in small drops of concentrated
Vectashield with DAPI, and subsequently sealed with nail varnish.
Image collection and analysis
Embryoswere imaged on either a Leica TCS SP5 confocalmicroscope
or Revolution XD Confocal System (Andor). Reconstructions of three-
dimensional images from sections and cell counts were performed
using Leica or Imaris software.
Statistical analysis
Probability (P) values were established using Student's t-test for
comparison between two samples.
Results
Human embryo culture to the late blastocyst stage
Human embryos were previously thawed and cultured in standard
IVF medium to the blastocyst stage (day 6–7) at 20% oxygen. Blastocyst
formation rates were low (17.5%, 25/143) andmany blastocysts did not
progress beyond the initial cavitation stages. The use of 5% oxygen has
been reported to be beneﬁcial for blastocyst formation rates
(Dumoulin et al., 1999; Waldenstrom et al., 2009). By reducing the
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mation rates increased signiﬁcantly (35.1%, 67/191),withmany embryos
progressing to day 7 and older. Therefore, for all subsequent experiments
a humidiﬁed atmosphere of 5% oxygen, 7% carbon dioxide and 37 °Cwas
adopted.
Putative hypoblast is segregated by day 7 of human development
The interplay between Nanog and Gata6 is suggested to be crucial
for the epiblast/hypoblast fate decision in mouse embryos (Plusa
et al., 2008). Although Nanog protein has been shown to localise to
a sub-population of cells in the ICM of human embryos at the mid/
late blastocyst stage (Cauffman et al., 2009; Hyslop et al., 2005;
Kimber et al., 2008), the identity of the Nanog-negative ICM cells
has not yet been investigated. We therefore investigated the expres-
sion of the hypoblast markers Gata6, Gata4 and Sox17 in human
blastocysts.
We ﬁrst examined human embryos at 6 days post-fertilisation.
Nanog is conﬁned to a few inner cells within the embryo (Fig. 1A).
Gata6 and Oct4 are widely expressed throughout the embryo, with
levels varying between individual cells, consistent with previous
data (Cauffman et al., 2005; Cauffman et al., 2006; Chen et al., 2009;
Kimber et al., 2008). Some inner cells exhibit high levels of Nanog
and low levels of Gata6 (Fig. 1B, arrows), whilst in other cells both
markers are expressed at about the same level (Fig. 1B, arrowheads).
This pattern is similar to that observed in the early mouse blastocyst
(Plusa et al., 2008).
At day 7 of development, Gata4 and Sox17, both markers of differ-
entiated hypoblast, are restricted to a narrow subset of cells within
the embryo (Fig. 1C). Signiﬁcantly, at this stage of development, this
pattern is mutually exclusive with Nanog expression. Some embryos
show Gata4 or Sox17-positive cells in what appears to be an epithelial
layer overlying the Nanog-positive epiblast on the blastocoelic sur-
face (Figs. 1C and 2C). This mirrors delamination of the hypoblast
seen in rodent blastocysts. Oct4 protein is much more restricted to
cells of the ICM than in earlier blastocysts, with staining in both the
epiblast and hypoblast (Fig. 1C), as is the case with early murine hy-
poblast (Silva et al., 2009). This may be due to slight differences in the
developmental age of the embryos, most likely reﬂecting variability in
their development in vitro. These embryos tended to exhibit reduced
total cell number, consistent with this (Fig. 1C, D). These observations
suggest that the human embryo at day 7 resembles the mouse em-
bryo at E4.5 when all three embryonic lineages can be distinguished.
Hypoblast segregation is not dependent upon FGF/Erk signalling
FGF/Mek inhibition in mouse preimplantation embryos has a
striking effect on lineage segregation (Chazaud et al., 2006; Nichols
et al., 2009; Yamanaka et al., 2010). Inhibition of FGF signalling di-
verts all cells of the ICM to the epiblast fate, bypassing the hypoblast.
We were interested in investigating whether the formation of human
hypoblast is also dependent on FGF signalling. If so, this would indi-
cate that the segregation of these lineages may be based on a con-
served mechanism. We performed experiments with human
embryos, adding inhibitors from the 6–8 cell stage. 1 μM PD0325901
is effective to block the formation of hypoblast in murine embryos if
applied before its segregation (Nichols et al., 2009). However, all
human embryos treated with 1 μM PD0325901 that developed to
late blastocysts showed Gata4 expression in a subset of cells, separate
from the Nanog-expressing population (Fig. 2A, D). To test whether
an alternative downstream pathway for FGF signalling is adopted
during human hypoblast induction, we introduced an inhibitor of
the FGF receptor, PD173074, in combination with PD0325901. Using
this combination, Gata4-positive cells were still identiﬁed in all the
human embryos investigated (Fig. 2C, D). We examined whether
PD0325901 could work synergistically with Chir99021, since theseare the components of 2i that effectively maintain naïve pluripotency
in cultures of murine ES cells (Ying et al., 2008). Gata4-positive cells
were still observed in embryos developed under these conditions
(Fig. 2B, D). In all three conditions that target FGF/Erk signalling,
human embryos possess Gata4 and Nanog-positive cells that are ex-
clusive to one another. Thus, the segregation of epiblast and hypo-
blast within the human embryo appears not to be dependent on
FGF signalling.
To eliminate the human-speciﬁc culture regime as a potential var-
iable in the response of embryos to FGF signalling inhibition, we cul-
tured murine embryos from the 8-cell-stage under identical
conditions. Mouse embryos responded as previously reported to
1 μM PD0325901 and 2i (Nichols et al., 2009) (Fig. 2E, G). We also
used the combination of PD0325901 and PD173074 that has been
shown to block hypoblast formation (Yamanaka et al., 2010). This
also prevented formation of Gata4 positive cells. Finally, we cultured
rat embryos under these conditions and found very similar responses
(Fig. 2F, G). This indicates that the effect of FGF inhibition is not spe-
ciﬁc to the mouse.
In both mouse and rat embryos, 1 μM PD0325901 reproducibly
blocks the formation of the hypoblast. The addition of Chir99021 to
PD0325901 (2i) seems to facilitate some hypoblast cells escaping
this block, especially in the rat embryo (Fig. 2G). The combination
of 0.5 μM PD0325901 and PD173074 reduces the emergence of hypo-
blast compared to control embryos, but is not as effective in blocking
hypoblast as 1 μM PD0325901. Despite the consistency of 1 μM
PD0325901 in its effects on mouse and rat embryos, it did not elimi-
nate the formation of Gata4-positive cells in the human embryo.
However, it should be noted that culturing human embryos for ex-
tended periods in FGF signalling inhibitors resulted in no detectable
detrimental effect on the Nanog positive population of cells.
Discussion
The ﬁrst two lineage decisions that mouse embryos undertake
during preimplantation development have been extensively studied.
Detailed examination of these decisions has not been performed in
human embryos due to the scarcity of available material and the
sub-optimal nature of culture regimes. Whilst the differentiation of
ICM and trophectoderm has been observed in human embryos
(Cauffman et al., 2009; Chen et al., 2009), there has been little evi-
dence for the segregation of the ICM into epiblast and hypoblast.
Nanog has previously been shown to be restricted to a subset of
ICM cells within the embryo at the blastocyst stage (Cauffman et al.,
2009), but it was not known if the Nanog-negative cells within the
ICM represented hypoblast. Fig. 1C demonstrates Gata4 expression
in cells negative for Nanog, indicating that the hypoblast is segregated
from the epiblast within the ICM by day 7 of human development. A
population of cells negative for Nanog is also immunoreactive to
Sox17 (Fig. 1D), an additional marker of hypoblast in the mouse, pro-
viding further evidence that hypoblast is formed in human embryos.
We have previously reported that the segregation of hypoblast in
mouse embryos is dependent upon FGF signalling (Nichols et al.,
2009). We sought to examine if this was also the case in human em-
bryos. Mouse embryos behaved as we have previously reported when
exposed to small molecule inhibitors targeting the FGF pathway
when we cultured them in the human embryo culturing regime
(Fig. 2E, G). The effect of inhibiting FGF signalling on lineage alloca-
tion in mouse embryos is not speciﬁc to this species: rat embryos be-
haved in a similar way (Fig. 2F, G). This observation indicates that the
role of FGF/Erk signalling is conserved amongst the early embryos of
these two species.
The effect of FGF inhibition on human embryos shows a number of
differences from the effects observed in rodents, even though the
concentrations used were well above their respective IC50 values.
Gata4-positive hypoblast still forms under conditions where it is
Fig. 1. Human embryos segregate putative hypoblast by day 7 of development. Human embryos were thawed and cultured in standard IVF medium until they formed cavitated
blastocysts, upon which they were moved to N2B27 medium. Embryos were ﬁxed and immunostained for Oct4 (white), Nanog (green) and Gata6 (red). At day 6 of in vitro devel-
opment (A) Nanog is restricted to a few cells within the embryo, whilst Gata6 and Oct4 are broadly expressed. Confocal images of two representative embryos with a maximum
projection of the 3D reconstruction of the blastocyst are shown. (B) A single slice in a z stack of each of the two embryos shown in (A), indicating that Nanog and Gata6 can both be
expressed highly in the same cell (arrowheads) or that Gata6 can be low as Nanog is high (arrows). (C and D) Embryos were developed to day 7 in vitro and immunostained for
Nanog (green), Oct4 (white) and Gata4 (red) (C) or Sox17 (red) (D). In contrast to the stainings observed at day 6, Oct4 is restricted to the cells of the ICM. Gata4 and Sox17 are
restricted to a subset of cells within the embryo, distinct from the Nanog positive cells: the putative hypoblast. In all embryos nuclei were counterstained with DAPI (blue). The total
number of cells in each embryo is written in the top right hand corner of the panel.
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of human hypoblast is not dependent on FGF signalling. The molecu-
lar mechanism of hypoblast segregation in the human embryo is still
unknown. Possible candidates include the transforming growth factor
(TGF) β family proteins that operate via SMAD transcription factors.
Human ES cell lines can be propagated in a state of primed pluripo-
tency in the presence of Activin (Vallier et al., 2005), a member ofthis family. Furthermore, TGFβ has been shown to maintain self-
renewal of trophectoderm stem cells (Erlebacher et al., 2004). It
may therefore be anticipated that blocking this pathway could shield
pluripotent cells from diverting to extra-embryonic lineages. The
mitogen-activated protein kinase P38α has been suggested to play a
role in branching morphogenesis of embryonic lung epithelium (Liu
et al., 2008), a derivative of the deﬁnitive endoderm that shares an
Fig. 2. Effect of FGF/Erk signalling inhibition on human epiblast and hypoblast compared with mouse and rat. Human embryos were thawed and cultured in standard IVF medium
until they formed cavitated blastocysts, upon which they were moved to N2B27 medium. Embryos were exposed to inhibitors from the 6–8 cell stage and developed until day 7 in
vitro. Embryos were immunostained for Oct4 (white), Nanog (green) and Gata4 (red). Confocal images were taken and 3D reconstructions of the embryos created. The addition of
1 μM PD0325901 (A), 2i (B) or 0.5 μM PD0325901 and 100 nM PD173074 (C) did not eliminate the segregation of the putative hypoblast as indicated by the expression of Gata4.
(D) Blastocysts were variable in their number of Nanog and Gata4-expressing cells within each experimental group and across experimental groups. This may be due to the inher-
ent variation between human embryos in vitro. The number of cells per embryo is written above each bar in the graph. Mouse (E) and rat (F) embryos were cultured from the 8-cell-
stage under the same culture regime as human embryos. The addition of small molecules that inhibit the FGF/Erk pathway result in the loss of hypoblast in these embryos, indi-
cating that hypoblast formation is dependent on FGF signalling in both the mouse and rat. The Nanog antibody utilised has a lower afﬁnity for the rat protein (F) than the
mouse (E). (G) Cells of the epiblast and hypoblast were counted in 3D reconstruction of embryos. * indicates a Pb0.05 indicating a statistically signiﬁcant difference between
two data sets. The statistical differences of the no factors group and inhibitor conditions were not plotted for clarity. In all embryos nuclei were counterstained with DAPI (blue).
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failed to detect any effect of suppression of hypoblast formation by
applying inhibitors of either of these pathways to early mouse or rat
embryos (data not shown), they have not yet been applied to
human embryos.
The Nanog-positive epiblast compartment is not reduced in
human embryos when they are cultured in the presence of inhibi-
tors for FGF/Erk and Gsk3 signalling (Fig. 2D). Human ES cellscannot survive exposure to 2i (Nichols and Smith, 2009). If the
Nanog-positive cells in the human embryo were the in vivo counter-
part of human ES cells, they may be expected to deteriorate in the
presence of small molecules targeting FGF/Erk signalling. The sur-
vival of Nanog-positive cells within the embryo suggests that it
may ultimately be possible to isolate cells that are independent of
FGF/Erk signalling from these embryos (Hanna et al., 2010; Smith,
2010).
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